Table 5.

The levels of the markers in HCC patients with different AFP levels and clinical stages

3-Hydroxy-2-butanoneStyreneDecane
AFP (μg/L)
    <4005.81 (2.06-16.20)19.88 (8.95-28.17)4.43 (1.82-15.84)
    >40010.31 (4.63-18.79)15.92 (3.59-20.70)6.84 (2.11-14.58)
    <400 vs >400P = 0.240P = 0.101P = 0.608
Stage
    I-II14.08 (4.42-18.88)19.88 (15.02-24.65)4.43 (1.77-8.46)
    III-IV5.47 (2.87-10.90)15.99 (4.63-24.07)10.46 (2.25-15.84)
    I-II vs III-IVP = 0.088P = 0.212P = 0.280
  • NOTE: The data are presented as median values (25th-75th percentile)